Cite
MLA Citation
D.E. Furst et al.. “AB0455 Disease duration, but not rheumatoid factor status, impacts clinical response in adalimumab-treated rheumatoid arthritis patients with an inadequate response to standard dmard therapy: Subgroup analysis of the DE020 continuation trial.” Annals of the rheumatic diseases, vol. 71, n.d., p. 663. http://access.bl.uk/ark:/81055/vdc_100135573391.0x00005e